A carregar...
Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer
The use of trastuzumab, a monoclonal antibody that targets the human epidermal growth factor receptor 2 (HER2) alteration present in 25 to 30% of breast cancers, has been associated with improved survival outcomes in both the adjuvant and metastatic settings. However, despite the robust clinical eff...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3251862/ https://ncbi.nlm.nih.gov/pubmed/22215104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.516 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|